[Gefapixant in the treatment of chronic coughing]

Inn Med (Heidelb). 2023 Apr;64(4):409-412. doi: 10.1007/s00108-022-01466-x. Epub 2023 Jan 27.

[Article in German]

Authors

T Kühlein¹, C Hasford², S Nitschmann³

Affiliations

¹ Allgemeinmedizinisches Institut, Universitätsklinikum Erlangen, Universitätsstr. 29, 91054, Erlangen, Deutschland. thomas.kuehlein@uk-erlangen.de.
² Department of Respiratory Medicine at the Royal London Hospital for Integrated Medicine (RLHIM), University College London Hospital (UCLH), 60 Great Ormond St, WC1N 3HR, London, Großbritannien.
³ , Lippetal, Deutschland.

PMID: 36705677
DOI: 10.1007/s00108-022-01466-x

No abstract available

MeSH terms

Chronic Disease
Cough* / drug therapy
Humans
Pyrimidines*
Sulfonamides

Substances

Gefapixant
Pyrimidines
Sulfonamides